This is a preview of subscription content, log in via an institution to check access.
Reference
Lin D, et al. Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis. CNS Drugs : 28 Apr 2021. Available from: URL: http://doi.org/10.1007/s40263-021-00815-y
Rights and permissions
About this article
Cite this article
Long-acting injectable antipsychotics do not increase healthcare costs. PharmacoEcon Outcomes News 878, 16 (2021). https://doi.org/10.1007/s40274-021-7702-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7702-3